Physician profile
Hailey Farris
NPI 1447514310
$641.44
in general payments reported to CMS, 2019-2025
12 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $78.58 · 2020: $52.69 · 2021: $103 · 2022: $210 · 2023: $84.28 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $196.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $282.62 | 2021-2025 | |
| Novo Nordisk INC | $155.33 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.86 | 2019-2020 | |
| Pfizer INC. | $27.62 | 2021 | |
| Verona Pharma, INC. | $26.04 | 2025 | Ohtuvayre |
| Lilly USA, LLC | $23.92 | 2019-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $17.92 | 2025 | Caplyta |
| Bayer Healthcare Pharmaceuticals INC. | $15.38 | 2025 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $14.44 | 2022 | |
| Gilead Sciences, INC. | $14.33 | 2023 | |
| Janssen Pharmaceuticals, INC | $13.77 | 2022 | |
| Corium, LLC | $12.21 | 2023 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hailey Farris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.